Carmignac Gestion Has $21.47 Million Stock Position in Doximity, Inc. $DOCS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Carmignac Gestion lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 16.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 370,000 shares of the company's stock after acquiring an additional 52,700 shares during the period. Carmignac Gestion owned approximately 0.20% of Doximity worth $21,471,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. VSM Wealth Advisory LLC acquired a new position in Doximity in the 1st quarter worth $29,000. Allworth Financial LP lifted its holdings in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI acquired a new position in shares of Doximity during the first quarter worth about $33,000. Spire Wealth Management grew its holdings in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after buying an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group raised its position in Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after buying an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Doximity

In other news, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director directly owned 6,360 shares of the company's stock, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $63.00, for a total value of $315,000.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $1,046,934. This represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,000 shares of company stock worth $2,140,940. Insiders own 31.30% of the company's stock.

Doximity Stock Performance

DOCS traded up $3.5630 during trading on Friday, reaching $67.6930. 1,637,248 shares of the stock were exchanged, compared to its average volume of 2,323,116. The stock's 50 day moving average price is $60.80 and its two-hundred day moving average price is $60.49. Doximity, Inc. has a twelve month low of $35.32 and a twelve month high of $85.21. The stock has a market cap of $12.68 billion, a P/E ratio of 67.69, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The company's quarterly revenue was up 15.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DOCS. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. KeyCorp boosted their price objective on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Raymond James Financial raised their target price on shares of Doximity from $65.00 to $75.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. Zacks Research lowered shares of Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Finally, BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price objective for the company in a research note on Monday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $66.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.